Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile chronic myelogenous leukemia.

M H Freedman1, Z Estrov, H S Chan

  • 1Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Canada.

The American Journal of Pediatric Hematology/Oncology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated real-time detection of drug-resistant Mycobacterium tuberculosis on a lab-on-a-disc by Recombinase Polymerase Amplification.

Analytical biochemistry·2018
Same author

Quantitative Phenotyping of Childhood Leukemia Identifies Variable and Invariable Cell Surface Antigens.

Leukemia & lymphoma·2016
Same author

Severity of airflow limitation, co-morbidities and management of chronic obstructive pulmonary disease patients acutely admitted to hospital.

Hong Kong medical journal = Xianggang yi xue za zhi·2013
Same author

Production and characterization of polyclonal and monoclonal antibodies against Aflatoxin B1 oxime-BSA in an enzyme-linked immunosorbent assay.

Mycotoxin research·2013
Same author

Aspergillus pachymeningitis mimicking nasopharyngeal carcinoma.

The Journal of laryngology and otology·2010
Same author

In vitro cytotoxicity of deferoxamine on human marrow haematopoietic progenitors.

Toxicology in vitro : an international journal published in association with BIBRA·2010

Juvenile chronic myelogenous leukemia (JCML) is a rare childhood cancer. This review details its key diagnostic features and recent advances in understanding JCML biology and treatment.

Area of Science:

  • Pediatric Hematology Oncology
  • Hematopoietic Stem Cell Biology
  • Monocyte-Histiocyte Lineage Disorders

Background:

  • Juvenile chronic myelogenous leukemia (JCML) is a rare malignant hematopoietic disorder affecting children under 4 years old.
  • JCML accounts for only 2% of childhood leukemias, leading to limited clinical experience.
  • Understanding JCML is crucial due to its rarity and impact on young children.

Purpose of the Study:

  • To summarize a decade of institutional research on JCML.
  • To provide a comprehensive literature review of JCML.
  • To highlight key diagnostic features and recent advances in JCML biology and treatment.

Main Methods:

  • Review of a 10-year institutional study on JCML.
  • Comprehensive survey of existing medical literature on JCML.

Related Experiment Videos

  • Analysis of diagnostic criteria, biological insights, and therapeutic strategies.

    • Main Results:

    • JCML presents unique characteristics distinct from other childhood leukemias.
    • Recent research has shed light on the underlying biology of JCML.
    • Advances in treatment protocols are emerging for JCML patients.

    Conclusions:

    • Accurate diagnosis of JCML relies on recognizing specific cardinal features.
    • Continued research into JCML biology is essential for developing targeted therapies.
    • Improved understanding and treatment strategies offer hope for children with JCML.